Kuros Biosciences AG (CSBTF)
OTCMKTS
· Delayed Price · Currency is USD
26.33
+0.20 (0.77%)
Apr 24, 2025, 10:29 AM EDT
Kuros Biosciences AG Cash Flow Statement
Financials in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | -4.29 | -13.73 | -14.6 | -7.54 | -11.52 | Upgrade
|
| Depreciation & Amortization | 2.61 | 2.7 | 2.75 | 2.81 | 2.63 | Upgrade
|
| Other Amortization | 0.02 | 0.05 | 0.09 | 0.07 | 0.04 | Upgrade
|
| Asset Writedown & Restructuring Costs | 5.1 | 4.54 | 3.6 | - | - | Upgrade
|
| Stock-Based Compensation | 5.13 | 0.92 | 1.03 | 0.39 | 0.75 | Upgrade
|
| Other Operating Activities | -1.56 | 3.9 | 1.05 | -0.99 | -0.41 | Upgrade
|
| Change in Accounts Receivable | -7.89 | -4.57 | -1.64 | -0.74 | -0.38 | Upgrade
|
| Change in Inventory | -4.65 | -2.48 | -1.59 | -0.34 | -0.52 | Upgrade
|
| Change in Accounts Payable | 5.56 | 0.06 | 0.49 | - | - | Upgrade
|
| Change in Other Net Operating Assets | 3.67 | 3.35 | 1.47 | 0.88 | 0.16 | Upgrade
|
| Operating Cash Flow | 3.14 | -8.84 | -7.35 | -5.46 | -9.24 | Upgrade
|
| Capital Expenditures | -1.1 | -0.32 | -0.39 | -0.3 | -0.06 | Upgrade
|
| Sale (Purchase) of Intangibles | -0.02 | -0.01 | -0.01 | -0.07 | -0.16 | Upgrade
|
| Investing Cash Flow | -1.11 | -0.33 | -0.4 | -0.37 | -0.22 | Upgrade
|
| Short-Term Debt Issued | - | - | - | 6.4 | 0.1 | Upgrade
|
| Total Debt Issued | - | - | - | 6.4 | 0.1 | Upgrade
|
| Short-Term Debt Repaid | - | - | -2.37 | - | - | Upgrade
|
| Long-Term Debt Repaid | -0.6 | -0.67 | -0.34 | -0.32 | -0.27 | Upgrade
|
| Total Debt Repaid | -0.6 | -0.67 | -2.72 | -0.32 | -0.27 | Upgrade
|
| Net Debt Issued (Repaid) | -0.6 | -0.67 | -2.72 | 6.08 | -0.17 | Upgrade
|
| Issuance of Common Stock | 1.94 | 0.5 | 6 | - | 18.62 | Upgrade
|
| Other Financing Activities | - | - | -0.06 | - | -1.37 | Upgrade
|
| Financing Cash Flow | 1.34 | -0.17 | 3.22 | 6.08 | 17.08 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.45 | -0.52 | -0.03 | -0.01 | -0.03 | Upgrade
|
| Net Cash Flow | 3.81 | -9.86 | -4.56 | 0.24 | 7.59 | Upgrade
|
| Free Cash Flow | 2.05 | -9.16 | -7.74 | -5.76 | -9.3 | Upgrade
|
| Free Cash Flow Margin | 2.71% | -27.29% | -43.05% | -41.72% | -230.25% | Upgrade
|
| Free Cash Flow Per Share | 0.06 | -0.25 | -0.23 | -0.18 | -0.38 | Upgrade
|
| Cash Interest Paid | 0.02 | 0.06 | 0.08 | 0.12 | 0.08 | Upgrade
|
| Cash Income Tax Paid | 0.87 | 0.55 | 0 | 0.05 | 0 | Upgrade
|
| Levered Free Cash Flow | 4.01 | -8.55 | -4.48 | 5.24 | -7.6 | Upgrade
|
| Unlevered Free Cash Flow | 4.11 | -8.43 | -4.48 | 6.1 | -7.07 | Upgrade
|
| Change in Net Working Capital | 2.61 | 8.6 | 1.79 | -8.69 | 2.91 | Upgrade
|
Updated Mar 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.